¿El uso de patiromer para el control de la hiperpotasemia crónica permite mantener el tratamiento con espironolactona en los pacientes con hipertensión arterial resistente con insuficiencia renal crónica e insuficiencia cardiaca? Análisis de un subgrupo de pacientes del estudio AMBER
Read
5425
Timeswas read the article
3304
Total PDF
2121
Total HTML
Article information
ISSN: 18889700Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 13 | 15 | 28 |
| 2025 5 | 101 | 97 | 198 |
| 2025 4 | 63 | 64 | 127 |
| 2025 3 | 62 | 69 | 131 |
| 2025 2 | 75 | 51 | 126 |
| 2025 1 | 72 | 90 | 162 |
| 2024 12 | 48 | 72 | 120 |
| 2024 11 | 55 | 93 | 148 |
| 2024 10 | 48 | 87 | 135 |
| 2024 9 | 49 | 61 | 110 |
| 2024 8 | 52 | 87 | 139 |
| 2024 7 | 40 | 62 | 102 |
| 2024 6 | 41 | 42 | 83 |
| 2024 5 | 52 | 58 | 110 |
| 2024 4 | 40 | 51 | 91 |
| 2024 3 | 40 | 29 | 69 |
| 2024 2 | 50 | 42 | 92 |
| 2024 1 | 50 | 32 | 82 |
| 2023 12 | 33 | 34 | 67 |
| 2023 11 | 45 | 37 | 82 |
| 2023 10 | 49 | 55 | 104 |
| 2023 9 | 48 | 44 | 92 |
| 2023 8 | 35 | 29 | 64 |
| 2023 7 | 45 | 66 | 111 |
| 2023 6 | 45 | 48 | 93 |
| 2023 5 | 54 | 48 | 102 |
| 2023 4 | 33 | 53 | 86 |
| 2023 3 | 36 | 61 | 97 |
| 2023 2 | 34 | 42 | 76 |
| 2023 1 | 51 | 65 | 116 |
| 2022 12 | 36 | 45 | 81 |
| 2022 11 | 41 | 77 | 118 |
| 2022 10 | 40 | 81 | 121 |
| 2022 9 | 49 | 88 | 137 |
| 2022 8 | 41 | 82 | 123 |
| 2022 7 | 57 | 112 | 169 |
| 2022 6 | 57 | 107 | 164 |
| 2022 5 | 57 | 116 | 173 |
| 2022 4 | 69 | 362 | 431 |
| 2022 3 | 49 | 151 | 200 |
| 2022 2 | 45 | 103 | 148 |
| 2022 1 | 45 | 68 | 113 |
| 2021 12 | 37 | 90 | 127 |
| 2021 11 | 32 | 111 | 143 |
| 2021 10 | 7 | 27 | 34 |
Show all
